Zvonko Miličević
-
- Diabetes Treatment and Management 51
- Diabetes Management and Research 34
- Diabetes, Cardiovascular Risks, and Lipoproteins 6
- Pharmacology top 0.5%
- Pharmacology and Obesity Treatment 21
- Physiology top 2%
- Surgery top 2%
- Pancreatic function and diabetes 13
-
- Metabolism, Diabetes, and Cancer 31
-
- Cardiovascular Function and Risk Factors 7
-
- Diabetes and associated disorders 5
- Co-authors
- Axel HauptJuan P. FríasMichael A. NauckYu DuShweta UrvaDeborah A. RobinsXuewei CuiCharles Benson
- Partner nations
- United StatesGermanyPoland
In The Last Decade
Zvonko Miličević
78 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Endocrinology, Diabetes and Metabolism 3.7k
- Pharmacology 1.3k
- Physiology 938
- Endocrine and Autonomic Systems 211
- Surgery 1.2k
Countries citing papers authored by Zvonko Miličević
This map shows the geographic impact of Zvonko Miličević's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zvonko Miličević with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zvonko Miličević more than expected).
Fields of papers citing papers by Zvonko Miličević
This network shows the impact of papers produced by Zvonko Miličević. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zvonko Miličević. The network helps show where Zvonko Miličević may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zvonko Miličević, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 6 | |
| 2 | 2025 | 1 | |
| 3 | Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidationbreakdown → | 2025 | 18 |
| 4 | 2025 | 7 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 12 | |
| 8 | 2023 | 19 | |
| 9 | 2021 | 123 | |
| 10 | 2020 | 171 | |
| 11 | 2019 | 35 | |
| 12 | 2019 | 8 | |
| 13 | Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trialbreakdown → | 2018 | 610 |
| 14 | 2017 | 25 | |
| 15 | 2017 | 92 | |
| 16 | 2017 | 17 | |
| 17 | 2012 | 13 | |
| 18 | Subclinical hypothyroidism and thyroid autoimmunity: risk factors for coronary heart disease? | 2011 | 0 |
| 19 | 2005 | 19 | |
| 20 | 2001 | 10 |
About Zvonko Miličević
Zvonko Miličević is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Family Practice, having authored 83 papers that have together received 4.5k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (51 papers), Diabetes Management and Research (34 papers), Metabolism, Diabetes, and Cancer (31 papers), Pharmacology and Obesity Treatment (21 papers), Pancreatic function and diabetes (13 papers), Cardiovascular Function and Risk Factors (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Diabetes and associated disorders (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.7k citations), Pharmacology (1.3k citations) and Physiology (938 citations). Zvonko Miličević has collaborated with scholars based in United States, Germany and Poland. Frequent co-authors include Axel Haupt, Juan P. Frías, Michael A. Nauck, Yu Du, Shweta Urva, Deborah A. Robins, Xuewei Cui, Charles Benson, Sirel Gurbuz and Melissa K. Thomas.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.